Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7401

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0904-7401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical structure of Cyclobenzaprine Hydrochloride showing its molecular formula representation including fused aromatic rings and side chains.*

FDA Label Image

5mg Carton Label (1b8ca715 31fa 4f92 93a4 7ab8de45cb8b 01)

Cyclobenzaprine Hydrochloride 5 mg film-coated oral tablets by Major Pharmaceuticals, presented in a unit dose package of 30 tablets (3 x 10). The label includes dosage information, storage instructions, and distributor details with NDC 0904-7400-04.*

FDA Label Image

10mg Carton Label (1b8ca715 31fa 4f92 93a4 7ab8de45cb8b 00)

Cyclobenzaprine Hydrochloride 10 mg film-coated tablets, USP in a blister card unit dose packaging. The label shows the Major Pharmaceuticals logo, NDC 0904-7401-61, 100 tablets (10 x 10) total count, and indicates prescription use only. The packaging includes basic dosage form and strength details, lot and storage instructions, and labeler information including address and website.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.